IL-6 expression-suppressing Lactobacillus reuteri strains alleviate gut microbiota-induced anxiety and depression in mice
Letters in Applied Microbiology · 2024
DOI: 10.1093/lambio/ovad144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2024. Verfasst von Xiaoyang Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neurobiota Research Center, College of Pharmacy, Kyung Hee University, Seoul 02447, South Korea. Hauptthemen laut MEDLINE: Limosilactobacillus reuteri, Gastrointestinal Microbiome, Neuroblastoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Ministry of Food and Drug Safety, Korea Healthy Industry Development Institute and the Medical Research Program.
Themen: Depression
Abstract (Originalsprache)
Fecal microbiota transplantation from patients with depression/inflammatory bowel disease (PDI) causes depression with gut inflammation in mice. Here, we investigated the effects of six Lactobacillus reuteri strains on brain-derived neurotropic factor (BDNF), serotonin, and interleukin (IL)-6 expression in neuronal or macrophage cells and PDI fecal microbiota-cultured microbiota (PcM)-induced depression in mice. Of these strains, L6 most potently increased BDNF and serotonin levels in corticosterone-stimulated SH-SY5Y and PC12 cells, followed by L3. L6 most potently decreased IL-6 expression in lipopolysaccharide (LPS)-stimulated macrophages. When L1 (weakest in vitro), L3, and L6 were orally administered in mice with PcM-induced depression, L6 most potently suppressed depression-like behaviors and hippocampal TNF-α and IL-6 expression and increased hippocampal serotonin, BDNF, 5HT7, GABAARα1, and GABABR1b expression, followed by L3 and L1. L6 also suppressed TNF-α and IL-6 expression in the colon. BDNF or serotonin levels in corticosterone-stimulated neuronal cells were negatively correlated with depression-related biomarkers in PcM-transplanted mice, while IL-6 levels in LPS-stimulated macrophage were positively correlated. These findings suggest that IL-6 expression-suppressing and BDNF/serotonin expression-inducing LBPs in vitro, particularly L6, may alleviate gut microbiota-involved depression with colitis in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurobiota Research Center, College of Pharmacy, Kyung Hee University, Seoul 02447, South Korea.
- PB Department, NVP Healthcare, Inc., Suwon 16209, South Korea.
Förderung
- Ministry of Food and Drug Safety
- Korea Healthy Industry Development Institute and the Medical Research Program
Zitieren
APA
Ma, X., Shin, J. W., Cho, J. H., Han, S. W., & Kim, D. H. (2024). IL-6 expression-suppressing Lactobacillus reuteri strains alleviate gut microbiota-induced anxiety and depression in mice. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovad144
Vancouver
Ma X, Shin JW, Cho JH, Han SW, Kim DH. IL-6 expression-suppressing Lactobacillus reuteri strains alleviate gut microbiota-induced anxiety and depression in mice. Letters in Applied Microbiology. 2024. doi:10.1093/lambio/ovad144
BibTeX
@article{Ma2024,
author = {Ma, Xiaoyang and Shin, Jeong-Woo and Cho, Jae-Hyun and Han, Seung-Won and Kim, Dong-Hyun},
title = {IL-6 expression-suppressing Lactobacillus reuteri strains alleviate gut microbiota-induced anxiety and depression in mice},
journal = {Letters in Applied Microbiology},
year = {2024},
doi = {10.1093/lambio/ovad144}
}
EUVIMED